Cargando…

Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history

There has been an increasing trend in the number of prescribed and over-the-counter drug recall over the last few years. The recall is usually due to company's discovery, customer's complaint or Food and Drug Administration (FDA) observation. The process of recall involves a planned specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagaich, Upendra, Sadhna, Divya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286830/
https://www.ncbi.nlm.nih.gov/pubmed/25599028
http://dx.doi.org/10.4103/2230-973X.147222
_version_ 1782351714523807744
author Nagaich, Upendra
Sadhna, Divya
author_facet Nagaich, Upendra
Sadhna, Divya
author_sort Nagaich, Upendra
collection PubMed
description There has been an increasing trend in the number of prescribed and over-the-counter drug recall over the last few years. The recall is usually due to company's discovery, customer's complaint or Food and Drug Administration (FDA) observation. The process of recall involves a planned specific course of action, which addresses the depth of recall, need for public warning, and the extent of effectiveness checks for the recall. The FDA review and/or recommend changes to the firm's recall strategy, as appropriate. The critical recall information list includes the identity of the product; summary of the failure; amount of product produced in the distribution chain and direct account. Product recalls clashes thousands of companies every year affecting: sales, testing customer relationships and disrupting supply chains. Drug recall is incubus for pharmaceutical companies. It effects the reputation of the company. The reason for the recall can be divided into two categories: manufacturing affined and safety/efficacy affined. It is essential to follow all the guidelines related to drug development and manufacturing procedure so as to minimize drug recall.
format Online
Article
Text
id pubmed-4286830
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-42868302015-01-16 Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history Nagaich, Upendra Sadhna, Divya Int J Pharm Investig Review Article There has been an increasing trend in the number of prescribed and over-the-counter drug recall over the last few years. The recall is usually due to company's discovery, customer's complaint or Food and Drug Administration (FDA) observation. The process of recall involves a planned specific course of action, which addresses the depth of recall, need for public warning, and the extent of effectiveness checks for the recall. The FDA review and/or recommend changes to the firm's recall strategy, as appropriate. The critical recall information list includes the identity of the product; summary of the failure; amount of product produced in the distribution chain and direct account. Product recalls clashes thousands of companies every year affecting: sales, testing customer relationships and disrupting supply chains. Drug recall is incubus for pharmaceutical companies. It effects the reputation of the company. The reason for the recall can be divided into two categories: manufacturing affined and safety/efficacy affined. It is essential to follow all the guidelines related to drug development and manufacturing procedure so as to minimize drug recall. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4286830/ /pubmed/25599028 http://dx.doi.org/10.4103/2230-973X.147222 Text en Copyright: © International Journal of Pharmaceutical Investigation http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Nagaich, Upendra
Sadhna, Divya
Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history
title Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history
title_full Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history
title_fullStr Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history
title_full_unstemmed Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history
title_short Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history
title_sort drug recall: an incubus for pharmaceutical companies and most serious drug recall of history
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286830/
https://www.ncbi.nlm.nih.gov/pubmed/25599028
http://dx.doi.org/10.4103/2230-973X.147222
work_keys_str_mv AT nagaichupendra drugrecallanincubusforpharmaceuticalcompaniesandmostseriousdrugrecallofhistory
AT sadhnadivya drugrecallanincubusforpharmaceuticalcompaniesandmostseriousdrugrecallofhistory